NCT04157712View on ClinicalTrials.gov

Multiple Ascending Dose Study of ALZ-801

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 26, 2015

Primary Completion Date

July 4, 2016

Study Completion Date

July 4, 2016

Conditions

Alzheimer Disease

Interventions

DRUG

ALZ-801 or matching placebo

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

Sponsors

Lead Sponsor

Collaborators (1)

Quotient Clinical

All Listed Sponsors

collaborator

Quotient Clinical

OTHER

lead

Alzheon Inc.

INDUSTRY